Treatment of chronic lymphocytic leukemia after discontinuation of Bruton's tyrosine kinase inhibitors Review

  

Authors:	Thompson, M. C.; Mato, A. R.
Review Title:	Treatment of chronic lymphocytic leukemia after discontinuation of Bruton's tyrosine kinase inhibitors
Keywords:	chronic lymphocytic leukemia; ibrutinib; treatment discontinuation; acalabrutinib; mechanisms of resistance
Journal Title:	Hematology/Oncology Clinics of North America
Volume:	35
Issue:	4
ISSN:	0889-8588
Publisher:	Elsevier Inc.
Date Published:	2021-08-01
Start Page:	793
End Page:	806
Language:	English
DOI:	10.1016/j.hoc.2021.03.008
PROVIDER:	scopus
PUBMED:	34174986
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107056227&doi=10.1016%2fj.hoc.2021.03.008&partnerID=40&md5=fa760e45f05d4c677d2e62a8fa3a4e08
Notes:	Review -- Export Date: 1 July 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/182321